Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
CAPLIPOINT.NSthis companyCaplin Point Laboratories Limited	₹2,502.50	17.84×	3.19×	5.23×	12.35×	56.5%	48.0%	31.5%	29.3%	17.9%	15.2%	2.9%	0×	-0.7×	790.9×	6.7×	0.4%	4	27.58	2	C
APLLTD.NSAlembic Pharmaceuticals Limited	₹1,017.30	19.32×	2.3×	1.77×	12.9×	3.1%	45.1%	10.9%	9.2%	11.9%	10.4%	2.0%	0.25×	1.11×	8.54×	1.76×	1.7%	4	—	2	B-
ASTRAZEN.NSAstraZeneca Pharma India Limited	₹6,529.00	103.53×	22.24×	8.53×	66.87×	74.4%	26.5%	10.3%	8.2%	21.5%	17.0%	0.0%	0.13×	-1.18×	51.99×	1.77×	0.4%	3	—	2	C+
GRANULES.NSGranules India Limited	₹799.20	25.35×	2.97×	2.81×	13.13×	-42.2%	43.0%	16.6%	11.1%	11.7%	10.1%	0.8%	0.3×	0.52×	7.77×	1.8×	0.2%	5	—	2	C+
INNOVACAP.NSInnova Captab Limited	₹1,068.90	28.01×	3.62×	2.46×	20.43×	-208.4%	32.6%	10.3%	8.8%	12.9%	8.4%	0.9%	0.32×	1.62×	9.74×	1.87×	0.3%	4	—	2	C
IOLCP.NSIOL Chemicals and Pharmaceuticals Limited	₹202.95	15.52×	1.19×	0.92×	8.2×	-108.0%	21.7%	8.1%	5.9%	7.7%	6.9%	1.8%	0.08×	0.26×	12.97×	1.78×	1.4%	4	—	2	C
Peer median	—	25.35×	2.97×	2.46×	13.13×	-42.2%	32.6%	10.3%	8.8%	11.9%	10.1%	0.9%	0.25×	0.52×	9.74×	1.78×	0.4%	4	—	2	—